Live from the NIH registry
Studies recruiting near Indio right now
Top 25 of 70 recruiting studies, sorted by proximity — each links to its official registry page
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
Head and Neck Squamous Cell Carcinoma, Hypopharyngeal Squamous Cell Carcinoma
Phase 2
Interventional 189 participants sought
Desert Regional Medical Center — Palm Springs, California (19.0 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain
Osteoarthritis, Knee, Diabetic Neuropathic Pain
Phase 2
Interventional 10,000 participants sought
Desert Oasis Healthcare Medical Group — Palm Springs, California (19.0 mi)
· Sponsor: Eli Lilly and Company
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Advanced Endometrial Carcinoma, Recurrent Endometrial Carcinoma
Phase 3
Interventional 255 participants sought
Eisenhower Medical Center — Rancho Mirage, California (10.2 mi)
· Sponsor: National Cancer Institute (NCI)
Long-Term Safety and Efficacy of Plozasiran in Adults With Hypertriglyceridemia
Hypertriglyceridemia
Phase 3
Interventional 869 participants sought
Research Site 229 — Palm Springs, California (19.0 mi)
· Sponsor: Arrowhead Pharmaceuticals
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
Obesity, Overweight
Phase 3
Interventional 1,980 participants sought
Desert Oasis Healthcare Medical Group — Palm Springs, California (19.0 mi)
· Sponsor: Eli Lilly and Company
Feasibility and Efficacy Study of the CardioPulmonary Management (CPM) System in Patients With Chronic Heart Failure
Heart Failure
N/A
Interventional 1,200 participants sought
Desert Oasis Healthcare — Palm Springs, California (19.0 mi)
· Sponsor: Analog Device, Inc.
PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR
Aortic Stenosis, Calcific, Aortic Valve Stenosis
N/A
Interventional 2,250 participants sought
Eisenhower Desert Cardiology Center — Rancho Mirage, California (10.2 mi)
· Sponsor: Edwards Lifesciences
A Study to Evaluate the Clinical Outcomes of Efgartigimod PH20 SC in Adults With New-onset Generalized Myasthenia Gravis (gMG)
New Onset Generalized Myasthenia Gravis (gMG)
Phase 4
Interventional 30 participants sought
Samir Macwan, M.D., Inc. (S corporation) — Rancho Mirage, California (10.2 mi)
· Sponsor: argenx
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Breast Cancer
N/A
Observational 30,000 participants sought
Comprehensive Cancer Center at Desert Regional Medical Center — Palm Springs, California (19.0 mi)
· Sponsor: Agendia
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma
Phase 3
Interventional 1,273 participants sought
Desert Regional Medical Center — Palm Springs, California (19.0 mi)
· Sponsor: SWOG Cancer Research Network
Study of the Shockwave Medical SkyRunner Carotid Intravascular Lithotripsy (IVL) System for the Treatment of Calcified Carotid Arteries Prior to Trans-Carotid Stenting (SKYWARD Trans-Carotid IDE [Investigational Device Exemption] Study)
Carotid Artery Calcification, Carotid Artery Diseases
N/A
Interventional 185 participants sought
Eisenhower Medical Center — Rancho Mirage, California (10.2 mi)
· Sponsor: Shockwave Medical, Inc.
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8
Phase 2
Interventional 56 participants sought
Eisenhower Medical Center — Rancho Mirage, California (10.2 mi)
· Sponsor: SWOG Cancer Research Network
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
NASH With Fibrosis, MASH With Fibrosis
Phase 3
Interventional 1,650 participants sought
Akero Clinical Study Site — Palm Springs, California (19.0 mi)
· Sponsor: Akero Therapeutics, Inc
Phase I Human Analytics (HALO) Study
Cardiovascular Diseases, Cancer
N/A
Observational 2,000 participants sought
Desert Medical Imaging — Indian Wells, California (6.3 mi)
· Sponsor: HALO Diagnostics
Confirmatory Clinical Evaluation of Novilase® Laser Therapy for Focal Destruction of Malignant Breast Tumors
Malignant Neoplasm of Breast
N/A
Interventional 122 participants sought
Eisenhower Health — Rancho Mirage, California (10.2 mi)
· Sponsor: Novian Health Inc.
E-Mindfulness Approaches for Living After Breast Cancer
Breast Cancer, Depression
Phase 3
Interventional 402 participants sought
Eisenhower Medical Center — Rancho Mirage, California (10.2 mi)
· Sponsor: NRG Oncology
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Positive
N/A
Interventional 739 participants sought
Desert Regional Medical Center — Palm Springs, California (19.0 mi)
· Sponsor: SWOG Cancer Research Network
Physica System Total Knee Replacement Registry Study
Osteoarthritis, Knee, Traumatic Arthritis
N/A
Interventional 800 participants sought
Eisenhower Desert Orthopedics Center - Harry and Diane Rinker Bldg — Rancho Mirage, California (10.2 mi)
· Sponsor: Limacorporate S.p.a
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
Lung Non-Small Cell Carcinoma
Phase 2
Interventional 88 participants sought
Eisenhower Medical Center — Rancho Mirage, California (10.2 mi)
· Sponsor: SWOG Cancer Research Network
Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
Alopecia Areata
Phase 3
Interventional 355 participants sought
Palmtree Clinical Research — Palm Springs, California (19.0 mi)
· Sponsor: Sun Pharmaceutical Industries, Inc.
A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Osteoarthritis Pain
Osteoarthritis, Knee, Chronic Pain
Phase 2
Interventional 150 participants sought
Desert Oasis Healthcare Medical Group — Palm Springs, California (19.0 mi)
· Sponsor: Eli Lilly and Company
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Breast Cancer
Phase 3
Interventional 3,960 participants sought
Eisenhower Medical Center — Rancho Mirage, California (10.2 mi)
· Sponsor: NRG Oncology
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Lung Non-Small Cell Carcinoma, Lung Non-Small Cell Squamous Carcinoma
Phase 3
Interventional 1,210 participants sought
Eisenhower Medical Center — Rancho Mirage, California (10.2 mi)
· Sponsor: National Cancer Institute (NCI)
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Obesity, Heart Failure
Phase 3
Interventional 5,610 participants sought
Desert Oasis Healthcare — Palm Springs, California (19.0 mi)
· Sponsor: Novo Nordisk A/S
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Multiple conditions
N/A
Observational 2,000 participants sought
Eisenhower Medical Center — Rancho Mirage, California (10.2 mi)
· Sponsor: Alliance for Clinical Trials in Oncology